The Dr. Tyna Show cover image

GLP-1 Agonists and the Gut Microbiome: Unveiling Their Role in Metabolic Health | Solo Episode

The Dr. Tyna Show

00:00

Exploring the Effects of Dilacrylotide on Gut Microbiome and Diabetes Management

This chapter explores the long-term effects of Dilacrylotide on the gut microbiome of type 2 diabetes patients, revealing significant changes in microbial abundance while maintaining stable diversity. It underscores the importance of understanding gut health's role in metabolic outcomes, emphasizing dietary and clinical intervention strategies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app